Dina Radenkovic Turner: Gameto Licenses IP to Revolutionize Human Gametogenesis
Dina Radenkovic Turner, Co-founder and CEO at Gameto, shared a post on LinkedIn:
“Today we announced that Gameto has licensed IP enabling the genetic induction of meiosis, a foundational biological process required to form eggs and sperm.
For decades, key aspects of human reproduction have remained difficult to study directly. Expanding our ability to investigate meiosis and human gametogenesis is an important step toward deepening scientific understanding in this field and, over the long term, supporting new possibilities in infertility research.
This is also a meaningful milestone in the broader progress toward in vitro gametogenesis.
In this short video, Gameto’s CSO, Christian Kramme, shares why this announcement matters and what it could enable moving forward.
Proceed to the video attached to the post.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Feb 2, 2026, 13:04Optimal GnRH Agonist Dosage for Oocyte Maturation – Fertility and Sterility
-
Feb 2, 2026, 12:39Family Planning Challenges for Women with Lupus – The Lupus Foundation of Australasia
-
Feb 2, 2026, 12:17Anis Feki: Innovative Strategies for Bowel Endometriosis Management
-
Feb 2, 2026, 12:10Revolutionizing Testicular Cell Cultivation with 3D Bioprinting – School of Infection, Inflammation and Immunology, University of Birmingham
-
Feb 2, 2026, 12:07Cesar Diaz Garcia: Age and Its Impact on Male Fertility
-
Feb 2, 2026, 12:04Karen Breeck: New WHO Guidelines Emphasize Fertility Education for All
-
Feb 2, 2026, 11:59Discover New Research and Outcomes in Reproductive Health – IIRRM
-
Feb 1, 2026, 17:36Impact of Non-Medical Treatments of Endometrioma on Pregnancy Outcomes – RBMO
-
Feb 1, 2026, 16:18Hossam Elzeiny: The Need for Clinically Relevant Studies in Fertility